Clindamycin
Presented byProfessor Dr. Imad A-J ThanoonClindamycin
Mechanism of actionPharmacokinetics
May be given Orally or parenterally Orally: Rapidly absorbed. Bioavailability is 90%. Widely concentrated in tissues including bones, and body fluids. It diffuses across the placenta. Metabolized in liver Excretion- urine and bileAntibacterial activity
Susceptible bacteriaMedical use
Bacteremia Bacterial Endocarditis Prophylaxis Deep Neck Infection Intraabdominal Infection Joint Infection Malaria Osteomyelitis Pelvic Inflammatory Disease Peritonitis Pneumonia Aspiration Pneumonia Sinusitis Skin or Soft Tissue Infection Surgical Prophylaxis Toxoplasmosis - Prophylaxis Toxoplasmosis Bacterial Infectionadverse drug reactions
Common adverse drug reactions associated with systemic clindamycin therapy — found in over 1% of people — include: diarrhea, pseudomembranous colitis ,nausea , vomiting, abdominal pain or cramps and/or rash.High doses (both intravenous and oral) may cause a metallic taste. Common adverse drug reactions associated with topical formulations - found in over 10% of people - include: dryness, burning, itching of skin.Hepatotoxicity & bone marrow suppression- rareClindamycin and dentistry
Why clindamycinClindamycin is a highly effective drug when used to fight dental infections. The reason is that Clindamycin is nearly completely absorbed (90%), and penetrates deeply into the soft tissues of the body, as well as bone, where dental infections reside.